Skip to content

Avanos Medical AVNS Cash received from option exercises

Cash received from option exercises at other companies

Scansource logo
ScansourceSCSC
$2K-86.7%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$1.22M
Henry Schein logo
Henry ScheinHSIC
$1M0.0%
Globus Medical logo
Globus MedicalGMED
Corvel logo
CorvelCRVL

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's cash received from option exercises.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's cash received from option exercises?
Avanos Medical (AVNS) reported cash received from option exercises of $400K in Q1 2026.
How has Avanos Medical's cash received from option exercises changed year-over-year?
Avanos Medical's cash received from option exercises decreased by 0.0% year-over-year, from $400K to $400K.
What does cash received from option exercises mean?
Represents the cash inflows received from employees or directors when they exercise vested stock options. This serves as a source of capital and reflects the conversion of equity-based compensation into company cash.